Supplementary Table S1 from Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC) (SWOG S1507, NCT-02642042)
Authors:
- Shirish M. GadgeelSGShirish M. Gadgeel
- Jieling MiaoJMJieling Miao
- Jonathan W. RiessJRJonathan W. Riess
- James MoonJMJames Moon
- Philip C. MackPMPhilip C. Mack
- Gregory J. GerstnerGGGregory J. Gerstner
- Timothy F. BurnsTBTimothy F. Burns
- Asma TajATAsma Taj
- Wallace L. AkerleyWAWallace L. Akerley
- Konstantin H. DragnevKDKonstantin H. Dragnev
- Noel LaudiNLNoel Laudi
- Mary W. RedmanMRMary W. Redman
Open Access
- 16 September 2024
- other
- Published by American Association for Cancer Research (AACR)